NasdaqCM - Delayed Quote USD
Aspire Biopharma Holdings, Inc. (ASBPW)
0.0600
+0.0100
+(20.00%)
As of April 22 at 4:00:00 PM EDT. Market Open.
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (1970) | Next Year (1970) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ASBPW | -- | -- | -- | -- |
| S&P 500 | 6.85% | 4.67% | 8.41% | 14.16% |
Related Tickers
XRTX.V XORTX Therapeutics Inc.
1.5000
+4.17%
ANL Adlai Nortye Ltd.
2.0000
+9.29%
INTS Intensity Therapeutics, Inc.
1.4100
-22.10%
XBIO Xenetic Biosciences, Inc.
2.5550
+6.90%
NEUP Neuphoria Therapeutics Inc.
5.20
+2.97%
APRE Aprea Therapeutics, Inc.
1.5300
-0.65%
MBX MBX Biosciences, Inc.
9.00
+4.17%
BOLT Bolt Biotherapeutics, Inc.
0.3580
-0.83%
COCP Cocrystal Pharma, Inc.
1.3635
-2.61%
GLYC GlycoMimetics, Inc.
0.2538
+11.32%